BOARD
- President: Alba Vergés i Bosch, Consellera de Salut
- 1st Vicepresident: Maria Àngels Chacón i Feixas, Conseller d’Empresa i Coneixement
- 2nd Vicepresident: Joan Elias García, Rector UB
- Secretary: Montserrat Figuerola Batista, Gerent de l’Àrea Metropolitana Sud de l’ICS
- Chair: Joan Gómez Pallarès, Director General de Recerca
- Chair: Albert Barberà Lluís, Director General de Recerca del Departament de Salut
- Chair: Domènec Espriu Climent, Vicerector Recerca UB
- Chair: Candela Calle Rodríguez, Directora General ICO
- Chair: Cristina Capdevila Aguilera, Directora de Centre HUB
- Chair: Josep M. Vilà Cortasa, President de l’Institut Català d’Oncologia
- Chair: Núria Marin Martínez, Alcaldessa
- Chair: Francesc Xavier Grau i Vidal, Secretari d’Univesitats i Recerca
- Chair: Lluís Rovira i Pato, Director de la Institució dels Centres de Recerca de Catalunya (CERCA)
- Chair: Iolanda Font de Rubinat Garcia, Subdirectora General de Recerca
- Chair: Jaume Reventós Puigjaner, Coordinador d’Estratègia i Relacions Institucionals
- Chair: Josep Batista Trobalón, Vicerector Personal Docent i Investigador
SCIENTIFIC ADVISORY BOARD
- Ernest Arenas Cases, MD, PhD. Professor of Stem Cell Neurobiology & Chairman of the Department of Medical Biochemistry and Biophysics. Karolinska Institut, Sweden
- Paolo Gasparini, PhD. Istituto di Ricovero e Cura a Carettere Scientifico maternoinfantile Burlo Garofolo, Trieste
- Lisardo Boscà Gomar, PhD. Centro de Investigaciones Biomédicas Alberto Sols, Madrid
- Robert Sackstein, MD, PhD. Professor, Harvard Medical School Director, Program of Excellence in Glycosciences. Physician, Brigham & Women’s Hospital/Dana Farber Cancer Institute, Boston, MA, USA
- Ana Aranda Iriarte, PhD. Departamento de Fisiopatología Endocrina y del Sistema Nervioso, Instituto de investigaciones Biomédicas “Albert Sols”
- Sonia Martínez Arca, PhD. Directora Gerente Agencia de Cnocimiento en Salud, ACIS
INTERNAL SCIENTIFIC COMITTEE
Program coordinators:
Cancer area:
1. Ramon Salazar (ICO/UB) – Molecular Mechanisms and Experimental Therapy in Oncology
2. Alex Vaquero (FIDIBELL) – Epigenetics and cancer biology
3. Xavier Bosch (ICO/UB) – Epidemiology, Public Health, Cancer Prevention and Palliative Care
Neuroscience area:
4. Francisco Ciruela (UB) – Neuroscience
Translational medicine area:
5. Eduard Montanya (HUB/UB) – Diabetes and metabolism
6. Virginia Nunes (FIDIBELL/UB) – Genes, disesase and therapy
7. Àngel Cequier (HUB/UB) – Cardiovascular, Respiratory and Systemic Diseases and cellular aging
8. Josep Manuel Llop (HUB/UB) – Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
9. Jordi Carratalá (HUB/UB) – Infectious disease and transplantation
Extended Executive board
10. Òscar Martínez Tirado (FIDIBELL) – Representative FIDIBELL
11. Josep Maria Cruzado (HUB/UB) – Representative HUB
Other members:
12. Francesc Xavier Matias- Guiu (HUB) – Scientific director Biobank
13. Cristina Muñoz (FIDIBELL) – Miguel Servet and/or Ramon y Cajal researcher
14. Eva González (FIDIBELL) – ERC researcher
15. Ruth de Diego (UB) – ICREA researcher
16. Miquel Angel Pujana (ICO) – Oncobell member
17. Maria Antonia Perelló (Viladecans/UB) – Viladecans researcher
18. Oriol Casanovas (ICO) – ERC researcher
19. Angel Raya (CMRB) – Regenerative medicine program coordinater
20. Montserrat Martín – Scientific director, Consorci Sanitari Integral
Organizational chart
*In 2018, the CMR[B] began a transition process to become a new research area within IDIBELL. This process is expected to be fully completed in January 2020.
General director
Gabriel Capellá
Scientific area
Josep Manuel Menchón
Strategy area
Marina Rigau
Business development & Innovation
Raquel Egea
Management
Magda Martí
People
